Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.75% is 11% below its 5-year average of 0.84%, around the middle of its 5-year range (0.00%–1.78%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.05% above its 12-month average of 0.73%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.75%.
DEBT TO ASSETS RATIO
0.75%
DEBT TO ASSETS RATIO AVG TTM
0.73%
DEBT TO ASSETS RATIO AVG 3Y
0.84%
DEBT TO ASSETS RATIO AVG 5Y
0.84%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+3.05%
CURRENT VS 3Y AVG
-10.49%
CURRENT VS 5Y AVG
-10.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 663 covered companies
CURRENT VS SECTOR MEDIAN
+648.40%
vs the sector median at left
Edgewise Therapeutics, Inc.
Market Cap
$4.40B
Debt to Assets Ratio
0.75%
TTM Avg
0.73%
3Y Avg
0.84%
5Y Avg
0.84%
Market Cap
$4.37B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.43B
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.45B
Debt to Assets Ratio
0.64%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.64B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.07B
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.66B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | $4.40B | 0.75% | 0.73% | 0.84% | 0.84% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.37B | 0.08% | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.43B | 0.41% | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | 0.64% | N/A | N/A | N/A |
| LivaNova PLC (LIVN)vs › | $4.13B | 0.13% | N/A | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 0.38% | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.65B | 0.20% | N/A | N/A | N/A |
| AbCellera Biologics Inc. (ABCL)vs › | $4.07B | 0.10% | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.66B | 0.09% | N/A | N/A | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.72B | 0.03% | N/A | N/A | N/A |
Debt/Assets
0.7%
Debt/Equity
0.01
Current Ratio
16.24
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.75% |
| 2026-03-31 | 0.73% |
| 2025-12-31 | 0.72% |
| 2025-09-30 | 0.72% |
| 2025-06-30 | 0.71% |
| 2025-03-31 | 1.00% |
| 2024-12-31 | 0.97% |
| 2024-09-30 | 0.87% |
| 2024-06-30 | 0.94% |
| 2024-03-31 | 0.95% |
| 2023-12-31 | 1.59% |
| 2023-09-30 | 1.78% |
| 2023-06-30 | 1.71% |
| 2023-03-31 | 1.63% |
| 2022-12-31 | 1.20% |
| 2022-09-30 | 0.71% |
| 2022-06-30 | 0.68% |
| 2022-03-31 | 0.81% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
